CIK 0001088856
- Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770487658
- Phone
- +1 650-688-8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,491,788
- in 15 filings, $25.2M under 10b5-1 plans
Net −$28,491,788. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-11-16 | ENRIGHT PATRICK G Director | Sale | −342 | $9.51 | $3K | 191,522 |
| 2016-11-15 | Longitude Venture Partners L.P. 10% owner | Sale | −154,359 | $9.55 | $1.5M | 14,362,573 |
| 2016-11-15 | Longitude Venture Partners L.P. 10% owner | Sale | −3,094 | $9.55 | $30K | 191,864 |
| 2016-11-15 | ENRIGHT PATRICK G Director | Sale | −154,359 | $9.55 | $1.5M | 14,362,573 |
| 2016-11-15 | ENRIGHT PATRICK G Director | Sale | −3,094 | $9.55 | $30K | 191,864 |
| 2016-11-11 | WILSON JAMES N Director | Exercise or conversion | +14,216 | $1.51 | $21K | 14,216 |
| 2016-11-11 | WILSON JAMES N Director | Sale | −14,216 | $9.10 | $129K | 0 |
| 2016-11-11 | WILSON JAMES N Director | Exercise or conversion · Stock Option (Right to Buy) | −14,216 | 0 | ||
| 2016-11-11 | MAHONEY DAVID L Director | Exercise or conversion | +30,000 | $2.70 | $81K | 1,199,320 |
| 2016-11-11 | MAHONEY DAVID L Director | Sale | −30,000 | $9.35 | $281K | 1,169,320 |
| 2016-11-11 | MAHONEY DAVID L Director | Exercise or conversion · Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2016-11-11 | BELANOFF JOSEPH K CHIEF EXECUTIVE OFFICER | Exercise or conversion | +200,000 | $1.50 | $300K | 2,364,195 |
| 2016-11-11 | BELANOFF JOSEPH K CHIEF EXECUTIVE OFFICER | Sale | −200,000 | $9.10 | $1.8M | 2,164,195 |
| 2016-11-11 | BELANOFF JOSEPH K CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2016-11-11 | WILSON JAMES N Director | Exercise or conversion | +14,216 | $1.51 | $21K | 915,283 |
| 2016-11-11 | WILSON JAMES N Director | Sale | −14,216 | $9.10 | $129K | 901,067 |
| 2016-11-11 | WILSON JAMES N Director | Exercise or conversion · Stock Option (Right to Buy) | −14,216 | 0 | ||
| 2016-11-10 | WILSON JAMES N Director | Exercise or conversion | +33,247 | $1.51 | $50K | 33,247 |
| 2016-11-10 | WILSON JAMES N Director | Sale | −33,247 | $8.90 | $296K | 0 |
| 2016-11-10 | WILSON JAMES N Director | Exercise or conversion · Stock Option (Right to Buy) | −33,247 | 14,216 |
Page 77 of 88 · 1,742 trades